Abstrakt

Przypisy

• 1. Adaramoye O.A., Akinwonmi O., Akanni O.: Effects of propofol,a sedative-hypnotic drug, on the lipid profile, antioxidant indices,and cardiovascular marker enzymes in wistar rats. ISRN Pharmacol.,2013; 2013: 230261
  Google Scholar
• 2. Aebi H.: Catalase in vitro. Methods Enzymol., 1984; 105: 121-126
  Google Scholar
• 3. Chen J., Gu Y., Shao Z., Luo J., Tan Z.: Propofol protects againsthydrogen peroxide-induced oxidative stress and cell dysfunctionin human umbilical vein endothelial cells. Mol. Cell Biochem., 2010;339: 43-54
  Google Scholar
• 4. Chikutei K., Oyama T.M., Ishida S., Okano Y., Kobayashi M., MatsuiH., Horimoto K., Nishimura Y., Ueno S.Y., Oyama Y.: Propofol,an anesthetic possessing neuroprotective action against oxidativestress, promotes the process of cell death induced by H2O2 in ratthymocytes. Eur. J. Pharmacol., 2006, 540: 18-23
  Google Scholar
• 5. De La Cruz J.P., Sedeño G., Carmona J.A., Sánchez de la Cuesta F.:The in vitro effects of propofol on tissular oxidative stress in the rat.Anesth. Analg., 1998; 87: 1141-1146
  Google Scholar
• 6. De La Cruz J.P., Villalobos M.A., Sedeño G., Sánchez De La Cuesta F.: Effect of propofol on oxidative stress in an in vitro model of anoxia-reoxygenationin the rat brain. Brain Res., 1998; 800: 136-144
  Google Scholar
• 7. Fábregas N., Rapado J., Gambús P.L., Valero R., Carrero E., SalvadorL., Nalda-Felipe M.A., Trocóniz I.F.: Modeling of the sedativeand airway obstruction effects of propofol in patients with Parkinsondisease undergoing stereotactic surgery. Anesthesiology, 2002;97: 1378-1386
  Google Scholar
• 8. Golden T.R., Patel M.: Catalytic antioxidants and neurodegeneration.Antioxid. Redox Signal., 2009; 11: 555-570
  Google Scholar
• 9. Habig W.H., Jakoby W.B.: Assays for differentiation of glutathioneS-transferases. Methods Enzymol., 1981; 77: 398-405
  Google Scholar
• 10. Hald A., Lotharius J.: Oxidative stress and inflammation in Parkinson’sdisease: is there a causal link? Exp. Neurol., 2005; 193: 279-290
  Google Scholar
• 11. Johnson W.M., Wilson-Delfosse A.L., Mieyal J.J.: Dysregulationof glutathione homeostasis in neurodegenerative diseases. Nutrients,2012; 4: 1399-1440
  Google Scholar
• 12. Kamat C.D., Gadal S., Mhatre M., Williamson K.S., Pye Q.N., HensleyK.: Antioxidants in central nervous system diseases: preclinicalpromise and translational challenges. J. Alzheimers Dis., 2008; 15:473-493
  Google Scholar
• 13. Karpińska A., Gromadzka G.: Oxidative stress and natural antioxidantmechanisms: the role in neurodegeneration. From molecularmechanisms to therapeutic strategies. Postępy Hig. Med.Dośw., 2013; 67: 43-53
  Google Scholar
• 14. Kulbacka J., Saczko J., Chwiłkowska A.: Oxidative stress in cellsdamage processes. Pol. Merkur. Lekarski, 2009; 27: 44-47
  Google Scholar
• 15. Lee M.C.: Assessment of oxidative stress and antioxidant propertyusing electron spin resonance (ESR) spectroscopy. J. Clin. Biochem.Nutr., 2013; 52: 1-8
  Google Scholar
• 16. Li W., Zhang Y., Liu Y., Yue F., Lu Y., Qiu H., Gao D., Gao Y., WuY., Wang Z., Huang R., Zhang C.: In vitro kinetic evaluation of thefree radical scavenging ability of propofol. Anesthesiology, 2012;116: 1258-1266
  Google Scholar
• 17. Liu Y.C., Chang A.Y., Tsai Y.C., Chan J.Y.: Differential protectionagainst oxidative stress and nitric oxide overproduction in cardiovascularand pulmonary systems by propofol during endotoxemia.J. Biomed. Sci., 2009; 16: 8
  Google Scholar
• 18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J.: Protein measurementwith the Folin phenol reagent. J. Biol. Chem., 1951; 193:265-275
  Google Scholar
• 19. Niki E., Yoshida Y., Saito Y., Noguchi N.: Lipid peroxidation:mechanisms, inhibition, and biological effects. Biochem. Biophys.Res. Commun., 2005; 338: 668-676
  Google Scholar
• 20. Ohkawa H., Ohishi N., Yagi K.: Assay for lipid peroxides in animaltissues by thiobarbituric acid reaction. Anal. Biochem., 1979;95: 351-358
  Google Scholar
• 21. Oztürk E., Demirbilek S., Köroğlu A., But A., Begeç Z.O., GülecM., Akyol O., Ersoy M.O.: Propofol and erythropoietin antioxidantproperties in rat brain injured tissue. Prog. Neuropsychopharmacol.Biol. Psychiatry, 2008; 32: 81-86
  Google Scholar
• 22. Paglia D.E., Valentine W.N.: Studies on the quantitative andqualitative characterization of erythrocyte glutathione peroxidase.J. Lab. Clin. Med., 1967; 70: 158-169
  Google Scholar
• 23. Ranjbar A., Sharifzadeh M., Karimi J., Tavilani H., Baeeri M.,Heidary Shayesteh T., Abdollahi M.: Propofol attenuates toxic oxidativestress by CCl4 in liver mitochondria and blood in rat. Iran J.Pharm. Res., 2014; 13: 253-262
  Google Scholar
• 24. Richterich R.: Chemia kliniczna. Warszawa: PZWL; 1971
  Google Scholar
• 25. Runzer T.D., Ansley D.M., Godin D.V., Chambers G.K.: Tissue antioxidantcapacity during anesthesia: propofol enhances in vivo redcell and tissue antioxidant capacity in a rat model. Anesth. Analg.,2002; 94: 89-93
  Google Scholar
• 26. Sanyal J., Bandyopadhyay S.K., Banerjee T.K., Mukherjee S.C.,Chakraborty D.P., Ray B.C., Rao V.R.: Plasma levels of lipid peroxidesin patients with Parkinson’s disease. Eur. Rev. Med. Pharmacol. Sci.,2009; 13: 129-132
  Google Scholar
• 27. Sharma A., Kaur P., Kumar B., Prabhakar S., Gill K.D.: Plasma lipidperoxidation and antioxidant status of Parkinson’s disease patientsin the Indian population. Parkinsonism Relat. Disord., 2008; 14: 52-57
  Google Scholar
• 28. Shukla V., Mishra S.K., Pant H.C.: Oxidative stress in neurodegeneration.Adv. Pharmacol. Sci., 2011; 2011: 572634
  Google Scholar
• 29. Tsai Y.C., Huang C.C., Chu L.M., Liu Y.C. Differential influence ofpropofol on different cell types in terms of the expression of variousoxidative stress-related enzymes in an experimental endotoxemiamodel. Acta Anaesthesiol. Taiwan., 2012; 50: 159-166
  Google Scholar
• 30. Vasileiou I., Xanthos T., Koudouna E., Perrea D., Klonaris C.,Katsargyris A., Papadimitriou L.: Propofol: a review of its non-anaestheticeffects. Eur. J. Pharmacol., 2009; 605: 1-8
  Google Scholar

Pełna treść artykułu